EverSource Wealth Advisors’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$102K Buy
1,548
+549
+55% +$34.9K ﹤0.01% 1416
2025
Q4
$63.5K Buy
999
+110
+12% +$6.84K ﹤0.01% 1590
2025
Q3
$48.9K Buy
889
+123
+16% +$5.07K ﹤0.01% 1725
2025
Q2
$25.3K Buy
766
+673
+724% +$23.4K ﹤0.01% 2113
2025
Q1
$3.74K Buy
93
+42
+82% +$1.93K ﹤0.01% 2639
2024
Q4
$2.4K Buy
51
+13
+34% +$675 ﹤0.01% 2646
2024
Q3
$2.01K Sell
38
-20
-34% -$1.11K ﹤0.01% 2548
2024
Q2
$3.42K Buy
58
+7
+14% +$423 ﹤0.01% 2356
2024
Q1
$3.13K Buy
51
+14
+38% +$1.08K ﹤0.01% 2230
2023
Q4
$3.09K Sell
37
-57
-61% -$2.06K ﹤0.01% 2042
2023
Q3
$2.77K Buy
94
+47
+100% +$1.56K ﹤0.01% 1910
2023
Q2
$1.53K Buy
47
+35
+292% +$1.29K ﹤0.01% 2102
2023
Q1
$422 Buy
+12
New +$490 ﹤0.01% 2261

Other funds holding CYTK